Literature DB >> 16160141

Stoichiometry of envelope glycoprotein trimers in the entry of human immunodeficiency virus type 1.

Xinzhen Yang1, Svetla Kurteva, Xinping Ren, Sandra Lee, Joseph Sodroski.   

Abstract

The human immunodeficiency virus type 1 (HIV-1) envelope glycoproteins (Envs) function as a trimer, mediating virus entry by promoting the fusion of the viral and target cell membranes. HIV-1 Env trimers induce membrane fusion through a pH-independent pathway driven by the interaction between an Env trimer and its cellular receptors, CD4 and CCR5/CXCR4. We studied viruses with mixed heterotrimers of wild-type and dominant-negative Envs to determine the number (T) of Env trimers required for HIV-1 entry. To our surprise, we found that a single Env trimer is capable of supporting HIV-1 entry; i.e., T = 1. A similar approach was applied to investigate the entry stoichiometry of envelope glycoproteins from amphotropic murine leukemia virus (A-MLV), avian sarcoma/leukosis virus type A (ASLV-A), and influenza A virus. When pseudotyped on HIV-1 virions, the A-MLV and ASLV-A Envs also exhibit a T = 1 entry stoichiometry. In contrast, eight to nine influenza A virus hemagglutinin trimers function cooperatively to achieve membrane fusion and virus entry, using a pH-dependent pathway. The different entry requirements for cooperativity among Env trimers for retroviruses and influenza A virus may influence viral strategies for replication and evasion of the immune system.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16160141      PMCID: PMC1211524          DOI: 10.1128/JVI.79.19.12132-12147.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  126 in total

1.  Characterization of an HIV-1 point mutant blocked in envelope glycoprotein cleavage.

Authors:  H G Guo; F M Veronese; E Tschachler; R Pal; V S Kalyanaraman; R C Gallo; M S Reitz
Journal:  Virology       Date:  1990-01       Impact factor: 3.616

2.  Intracellular processing of the gp160 HIV-1 envelope precursor. Endoproteolytic cleavage occurs in a cis or medial compartment of the Golgi complex.

Authors:  B S Stein; E G Engleman
Journal:  J Biol Chem       Date:  1990-02-15       Impact factor: 5.157

3.  Quantitative infectivity assay for HIV-1 and-2.

Authors:  P L Nara; P J Fischinger
Journal:  Nature       Date:  1988-03-31       Impact factor: 49.962

Review 4.  The human immunodeficiency virus and its pathogenesis.

Authors:  J A Levy
Journal:  Infect Dis Clin North Am       Date:  1988-06       Impact factor: 5.982

5.  Mutational analysis of the cleavage sequence of the human immunodeficiency virus type 1 envelope glycoprotein precursor gp160.

Authors:  E O Freed; D J Myers; R Risser
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

6.  Biosynthesis, cleavage, and degradation of the human immunodeficiency virus 1 envelope glycoprotein gp160.

Authors:  R L Willey; J S Bonifacino; B J Potts; M A Martin; R D Klausner
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

7.  Formation of mixed hemagglutinin trimers in the course of double infection with influenza viruses belonging to different subtypes.

Authors:  E I Sklyanskaya; M Shie; Y S Komarov; S S Yamnikova; N V Kaverin
Journal:  Virus Res       Date:  1988-05       Impact factor: 3.303

8.  Endoproteolytic cleavage of gp160 is required for the activation of human immunodeficiency virus.

Authors:  J M McCune; L B Rabin; M B Feinberg; M Lieberman; J C Kosek; G R Reyes; I L Weissman
Journal:  Cell       Date:  1988-04-08       Impact factor: 41.582

9.  Nonneutralizing antibodies to the CD4-binding site on the gp120 subunit of human immunodeficiency virus type 1 do not interfere with the activity of a neutralizing antibody against the same site.

Authors:  Carolina Herrera; Catherine Spenlehauer; Michael S Fung; Dennis R Burton; Simon Beddows; John P Moore
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

10.  Posttranslational oligomerization and cooperative acid activation of mixed influenza hemagglutinin trimers.

Authors:  F Boulay; R W Doms; R G Webster; A Helenius
Journal:  J Cell Biol       Date:  1988-03       Impact factor: 10.539

View more
  89 in total

1.  Super-resolution imaging of C-type lectin and influenza hemagglutinin nanodomains on plasma membranes using blink microscopy.

Authors:  Michelle S Itano; Christian Steinhauer; Jürgen J Schmied; Carsten Forthmann; Ping Liu; Aaron K Neumann; Nancy L Thompson; Philip Tinnefeld; Ken Jacobson
Journal:  Biophys J       Date:  2012-04-03       Impact factor: 4.033

2.  Major antiparallel and minor parallel β sheet populations detected in the membrane-associated human immunodeficiency virus fusion peptide.

Authors:  Scott D Schmick; David P Weliky
Journal:  Biochemistry       Date:  2010-11-24       Impact factor: 3.162

Review 3.  Aiming to induce broadly reactive neutralizing antibody responses with HIV-1 vaccine candidates.

Authors:  Barton F Haynes; David C Montefiori
Journal:  Expert Rev Vaccines       Date:  2006-06       Impact factor: 5.217

4.  Dynamics of HIV neutralization by a microbicide formulation layer: biophysical fundamentals and transport theory.

Authors:  Anthony R Geonnotti; David F Katz
Journal:  Biophys J       Date:  2006-06-30       Impact factor: 4.033

5.  Time frames for neutralization during the human immunodeficiency virus type 1 entry phase, as monitored in synchronously infected cell cultures.

Authors:  Hillel Haim; Israel Steiner; Amos Panet
Journal:  J Virol       Date:  2007-01-24       Impact factor: 5.103

6.  Antibody binding in proximity to the receptor/glycoprotein complex leads to a basal level of virus neutralization.

Authors:  Xinzhen Yang; Inna Lipchina; Michelle Lifton; Liping Wang; Joseph Sodroski
Journal:  J Virol       Date:  2007-05-30       Impact factor: 5.103

7.  Mechanisms of receptor/coreceptor-mediated entry of enveloped viruses.

Authors:  Sarah A Nowak; Tom Chou
Journal:  Biophys J       Date:  2009-04-08       Impact factor: 4.033

8.  A novel self-replicating chimeric lentivirus-like particle.

Authors:  Christy K Jurgens; Kelly R Young; Victoria J Madden; Philip R Johnson; Robert E Johnston
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

9.  Transcriptional repression and RNA silencing act synergistically to demonstrate the function of the eleventh component of the vaccinia virus entry-fusion complex.

Authors:  Cindy L Wolfe; Suany Ojeda; Bernard Moss
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

10.  Modeling how many envelope glycoprotein trimers per virion participate in human immunodeficiency virus infectivity and its neutralization by antibody.

Authors:  Per Johan Klasse
Journal:  Virology       Date:  2007-09-07       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.